CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
METLINK aims to uncover connections between metabolic genes and cancer growth mechanisms using CRISPR/Cas9 technology. By screening various metabolic pathways in human fibroblast cells, the project seeks to identify potential new targets for cancer treatment.
Metabolism is crucial for cellular survival.
The large amount of evidence covering metabolic entries is mainly about theenzymatic processes and single reactions happening within the metabolic map, but there is poorer understanding of thecellular growth signaling network and regulation around metabolism.
With METLINK we aim at identifying new andpreviously undiscovered selective links between metabolic genes and cellular growth pro-survival mechanisms.
The hits willbe identified with the use of a…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
